Australia's largest stock trading and investment forum Australia's #1 stock forum

NSB

12.8%

3.4¢ neuroscientific biopharmaceuticals ltd

Ann: Broker Briefing Investor Webinar, page-43

First 43 Last

Share
Profile

Follow
Gymjunky

4,104 Posts.

948

19/09/21

07:54

Post #: 56180553
Share

Originally posted by LawyerTrader: ↑

I said I wasn't going to post on topic again, but having reflected over the week, I think I may owe Dr Heaton an apology. My language was certainly intemperate. If I sounded harsh, believe me, I am much, much harsher on myself.

When I first started out as an advocate, I would over-prepare my appearances to the point where I would repeat my submissions to myself, over and over again. I would even do mock presentations to family and friends. Anyone who would offer constructive criticism. The law is an adversarial profession, and it doesn't get much more cut throat than the court room. That's why I was irked. Let's just say my buttons were pushed. But, still, this is a public forum. I should have expressed myself differently.

No one says it's easy. Far from it. But it can become easier with preparation and visualisation. And practice. Lots of it.

Anyway, this really IS my last post on this topic.

It was a great week. Good luck to all holders.

Expand

There scientist they're not tv presenters they look through microscopes they don't make videos.

NSB Price at posting: 45.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ZER

Zeta Resources seeks to resolve the Panoramic takeover story

NAM

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

4DX

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

There are more pages in this discussion • 1 more message in this thread...

First 43 Last

Add NSB (ASX) to my watchlist

(20min delay)
Last 3.4¢		Change -0.005(12.8%)		Mkt cap ! $4.916M

Open	High	Low	Value	Volume
3.7¢	3.7¢	3.4¢	$21.49K	608.0K

Buyers (Bids)

No.	Vol.	Price($)
3	7060	3.4¢

Sellers (Offers)

Price($)	Vol.	No.
3.8¢	12035	2

View Market Depth

No.	Vol.	Price($)
3	7060	0.034
3	163333	0.033
1	200000	0.032
1	500000	0.031
3	662332	0.030

Price($)	Vol.	No.
0.038	12035	2
0.039	3092	1
0.040	50000	1
0.041	200000	1
0.043	40000	1

Last trade - 15.58pm 27/09/2024 (20 minute delay)

NSB (ASX) Chart

Ann: Broker Briefing Investor Webinar, page-43

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Zeta Resources seeks to resolve the Panoramic takeover story

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Broker Briefing Investor Webinar, page-43

Top Stories

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Zeta Resources seeks to resolve the Panoramic takeover story

ACCC seeks Olam divestments before its acquisition of Namoi Cotton can go ahead

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

The winners & losers on market if negative gearing were gone

The market's shrugged at China's stimulus measures all year. Why is this one different?

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

4DMedical lands Philips US reseller deal with eye to Veterans Affairs' market post-lung damage

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News